Analyst firms · BofA Securities · SYK
BofA Securities SYK price target and rating history
Stryker Corporation (SYK) · Health Care
BofA Securities rates Stryker Corporation (SYK) Buy with a $315 price target, as of its latest action on Sep 5, 2023. It has published 3 rating actions on SYK since March 2022, including 1 upgrade and 1 downgrade. Across 8 firms with a SYK price target in the last 12 months, the median target is $393.50.
- Current rating
- Buy
- Price target
- $315
- Median target, all firms
- $393.50
- Actions on SYK
- 3
BofA Securities price target on SYK
Every BofA Securities rating on SYK
- Sep 5, 2023
- Jul 11, 2022
- Mar 2, 2022
How other firms rate SYK
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Canaccord Genuity | Hold | $300 | Oct 30, 2026 |
| Barclays | Overweight | $375 | Oct 7, 2026 |
| Wolfe Research | Peer Perform | Aug 13, 2026 | |
| UBS | Buy | $400 | Jul 28, 2026 |
| BMO Capital Markets | Outperform | $369 | Jul 9, 2026 |
| Leerink Partners | Outperform | $410 | Apr 13, 2026 |
| William Blair | Outperform | Feb 20, 2026 | |
| TD Cowen | Hold | $387 | Jan 27, 2026 |
| Raymond James | Outperform | $418 | Jan 6, 2026 |
| Citizens JMP | Mkt Outperform | $440 | Dec 19, 2025 |
Questions about BofA Securities and SYK
- What is BofA Securities's price target for SYK?
- BofA Securities's latest stated price target for Stryker Corporation (SYK) is $315, from its action on Sep 5, 2023.
- What is BofA Securities's rating on SYK?
- BofA Securities rates SYK Buy, a bullish rating, as of Sep 5, 2023.
- When did BofA Securities last change its view on SYK?
- On Sep 5, 2023, BofA Securities upgrades to Buy from Neutral, price target $310 to $315.
- How does BofA Securities's SYK target compare with other analysts?
- Across 8 firms with a SYK price target in the last 12 months, the median target is $393.50.
More SYK rating histories
All BofA Securities ratingsSYK news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.